                         SEQUENCE LISTING

<110>  Ionis Pharmaceuticals, Inc.
 
<120>  COMPOUNDS AND METHODS FOR INCREASING ANTISENSE ACTIVITY

<130>  CORE0133WO

<150>  62/119,709
<151>  2015-02-23

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucletide

<400>  1
ctgctagcct cuggatttga                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
ctgctagcct ctggatttga                                                   20


<210>  3
<211>  28
<212>  RNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  3
agcaguucuc aaauccagag gcuagcag                                          28


<210>  4
<211>  28
<212>  RNA
<213>  Artificial sequencae

<220>
<223>  Synthetic oligonucleotide

<400>  4
agcaguucgu gauggguuug ucugcgcu                                          28


<210>  5
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  5
gtcatcgtca tcctcatcat                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  6
cagcaggcaa ctgtcgctga                                                   20


<210>  7
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  7
ggcatatgca gataatgttc                                                   20


<210>  8
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  8
ttttggcaaa gtaatcgtcc                                                   20


<210>  9
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  9
taaagtgata atctttgtcg                                                   20


<210>  10
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  10
atccctttct tccgcatgtg                                                   20


